Total Funding
51
44
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
218303
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
- David Steinberg: Co-FounderPast Role: Vedanta Biosciences, Founding CEO
- Chen Schor: Co-Founder, President & CEOPast Role: Teva Pharmaceuticals, VP, Global Business Development
About the Company
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.The Company develops medicines and therapies to treat aging-related diseases and conditions such as cancer, heart disease, neurodegenerative diseases, and diabetes mellitus.
resTORbio serves clients in the State of Massachusetts.
Women Founded
